P84.02 A Phase II Trial of Alectinib-Refractory Non-Small-Cell Lung Cancer with EML4-ALK Fusion Genes; Okayama Lung Cancer Study Group 1405

Autor: Yokoyama, T., Yoshioka, H., Harada, D., Kozuki, T., Isozaki, H., Bessho, A., Hosokawa, S., Takata, I., Takigawa, N., Hotta, K., Kiura, K.
Zdroj: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S655-S656
Databáze: ScienceDirect